Ultragenyx Pharmaceutical(RARE) - 2025 Q4 - Earnings Call Transcript

Ultragenyx Pharmaceutical (NasdaqGS:RARE) Q4 2025 Earnings call February 12, 2026 05:00 PM ET Speaker10Good afternoon, and welcome to the Ultragenyx's fourth quarter and full year 2025 financial results conference call. At this time, all participants are in a listen-only mode. At the end of the prepared remarks, you will have an opportunity to ask questions during the Q&A portion of the call. It is now my pleasure to turn the call to Joshua Higa, Vice President of Investor Relations.Speaker5Thank you. We've ...